Dr Abhijit Bhattacharya, MS, Central Hospital Kalla, Eastern Coalfields Ltd., assesses an x-ray of a TB patient. Credit: ILOBy Ed HoltBRATISLAVA, Jul 21 2023 (IPS) In a surprise move, pharma giant Johnson and Johnson (J&J) has agreed not to enforce some of its patents on a lifesaving TB drug, making generic versions available in many…

This content is for Member members only.
Log In Register
Please follow and like us:
Pin Share